ID   OUS-11
AC   CVCL_3108
SY   OUS11
DR   BTO; BTO:0003968
DR   BioSample; SAMN03472481
DR   GEO; GSM827565
DR   JCRB; JCRB1034
DR   JCRB; NIHS0313
DR   Wikidata; Q54936819
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: ~23 hours (Note=Lot 11102015) (JCRB=JCRB1034).
CC   Omics: SNP array analysis.
CC   Donor information: Established from the normal tissue of a lung cancer patient.
CC   Discontinued: JCRB; NIHS0313; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB1034
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458;
RA   Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P.,
RA   Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J.,
RA   Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C.,
RA   Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J.,
RA   Haber D.A.;
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//